{"id":"NCT01722331","sponsor":"Sun Pharmaceutical Industries Limited","briefTitle":"A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)","officialTitle":"A 64-Week, Phase 3, Randomized, Placebo-Controlled, Parallel Design Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous Tildrakizumab (SCH 900222/MK-3222), Followed by an Optional Long-Term Safety Extension Study, in Subjects With Moderate-to-Severe Chronic Plaque Psoriasis (Protocol No. MK-3222-010)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-12-06","primaryCompletion":"2015-10-28","completion":"2021-11-10","firstPosted":"2012-11-06","resultsPosted":"2018-06-13","lastUpdate":"2022-03-23"},"enrollment":772,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Plaque Psoriasis"],"interventions":[{"type":"DRUG","name":"Tildrakizumab 200 mg","otherNames":["MK-3222, SCH 900222"]},{"type":"DRUG","name":"Tildrakizumab 100 mg","otherNames":["MK-3222, SCH 900222"]},{"type":"DRUG","name":"Matching Placebo","otherNames":[]}],"arms":[{"label":"Tildrakizumab 200 mg","type":"EXPERIMENTAL"},{"label":"Tildrakizumab 100 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study is being conducted to evaluate the efficacy and safety/tolerability of subcutaneous tildrakizumab (MK-3222), followed by an optional long-term safety extension study, in participants with moderate-to-severe chronic plaque psoriasis.","primaryOutcome":{"measure":"Percentage of Participants With Psoriasis Area Sensitivity Index 75 (PASI-75) Response at Week 12 (Base Study)","timeFrame":"Week 12 (or end of trial if prior to Week 12)","effectByArm":[{"arm":"Tildrakizumab 200 mg (Part 1)","deltaMin":62.3,"sd":null},{"arm":"Tildrakizumab 100 mg (Part 1)","deltaMin":63.8,"sd":null},{"arm":"Placebo (Part 1)","deltaMin":5.8,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG001 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":15},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["28596043","40365708","36098877","33630387","32162721","31268369","31218661","30915660"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":308},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Psoriasis"]}}